Thousands of patients have signed up in a few days to support a large-scale NHS trial for potential treatments for COVID-19 in the UK, one of the countries worst hit by the global pandemic.
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
